We are live on ! Find out more
Mitsubishi UFJ Asset Management

Mitsubishi UFJ Asset Management Portfolio holdings

AUM $180B
1-Year Est. Return 37.51%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$12.9B
AUM Growth
+$2.06B
Cap. Flow
+$696M
Cap. Flow %
5.38%
Top 10 Hldgs %
21.98%
Holding
1,047
New
43
Increased
776
Reduced
154
Closed
22

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$42.1M
2
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$39.7M
3
AMZN icon
Amazon
AMZN
+$25.3M
4
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$24.1M
5
MSFT icon
Microsoft
MSFT
+$23M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$20.2M
2
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$9.18M
3
EL icon
Estee Lauder
EL
+$7.58M
4
CL icon
Colgate-Palmolive
CL
+$6.1M
5
CAG icon
Conagra Brands
CAG
+$5.45M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Consumer Discretionary 12.53%
3 Healthcare 12.45%
4 Financials 11.19%
5 Communication Services 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
926
Xencor
XNCR
$1.64B
$259K ﹤0.01%
5,937
-140
-2% -$5.79K
RESI
927
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$258K ﹤0.01%
15,923
+2,686
+20% +$37.3K
UA icon
928
Under Armour Class C
UA
$2.23B
$256K ﹤0.01%
17,186
– –
TBIO
929
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$253K ﹤0.01%
13,708
+4,483
+49% +$80.2K
BBBY
930
Bed Bath & Beyond
BBBY
$407M
$250K ﹤0.01%
5,741
-4,180
-42% -$247K
FOLD
931
DELISTED
Amicus Therapeutics
FOLD
$250K ﹤0.01%
10,845
-4,574
-30% -$93.5K
RPT
932
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$247K ﹤0.01%
28,563
+5,583
+24% +$37.7K
CUB
933
DELISTED
Cubic Corporation
CUB
$243K ﹤0.01%
3,922
+313
+9% +$19K
ORTX
934
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$242K ﹤0.01%
5,598
+3,520
+169% +$158K
BLUE
935
DELISTED
bluebird bio
BLUE
$236K ﹤0.01%
421
+178
+73% +$113K
VIR icon
936
Vir Biotechnology
VIR
$1.51B
$236K ﹤0.01%
+8,799
New +$286K
DRNA
937
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$235K ﹤0.01%
10,648
+2,270
+27% +$50K
CELL
938
DELISTED
PhenomeX Inc. Common Stock
CELL
$232K ﹤0.01%
+2,599
New +$219K
OII icon
939
Oceaneering
OII
$5.05B
$230K ﹤0.01%
28,923
+1,189
+4% +$6.94K
TCRT icon
940
Alaunos Therapeutics
TCRT
$4.81M
$230K ﹤0.01%
608
+166
+38% +$66K
ATRA icon
941
Atara Biotherapeutics
ATRA
$80.6M
$228K ﹤0.01%
464
-221
-32% -$102K
LGND icon
942
Ligand Pharmaceuticals
LGND
$5.76B
$224K ﹤0.01%
3,605
+1,318
+58% +$75.1K
WKHS icon
943
Workhorse Group
WKHS
$34.1M
$221K ﹤0.01%
4
-13
-76% -$846K
NWS icon
944
News Corp Class B
NWS
$17.7B
$216K ﹤0.01%
12,146
+3,795
+45% +$61.1K
ADVM
945
DELISTED
Adverum Biotechnologies
ADVM
$214K ﹤0.01%
1,978
+1,017
+106% +$126K
AHRT
946
AH Realty Trust
AHRT
$501M
$213K ﹤0.01%
+18,941
New +$192K
AXDX
947
DELISTED
Accelerate Diagnostics
AXDX
$213K ﹤0.01%
2,812
+16
+0.6% +$1.43K
DTIL icon
948
Precision BioSciences
DTIL
$207M
$213K ﹤0.01%
+852
New +$209K
WIT icon
949
Wipro
WIT
$19.5B
$210K ﹤0.01%
74,466
+3,850
+5% +$9.93K
JMIA
950
Jumia Technologies
JMIA
$720M
$209K ﹤0.01%
+5,168
New +$126K
36 37
38
39 40

Similar funds

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Mitsubishi UFJ Asset Management held 1,047 positions worth $12.9B, up 19% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mitsubishi UFJ Asset Management deployed $696M of net new capital in Q4 2020, opening 43 new positions and adding to 776 existing holdings. Its largest new stake was Goosehead Insurance: 40,600 shares worth $5.07M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $20.2M trimmed.

  • Mitsubishi UFJ Asset Management's largest Q4 2020 buy was Goosehead Insurance: 40,600 shares worth $5.07M.
  • Mitsubishi UFJ Asset Management added most to Tesla in Q4 2020, an estimated $42.1M increase.
  • Mitsubishi UFJ Asset Management's biggest Q4 2020 reduction was Amgen, cutting an estimated $20.2M.
  • Mitsubishi UFJ Asset Management fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $2.31M.
  • Mitsubishi UFJ Asset Management's ten largest holdings make up 22% of its $12.9B portfolio in Q4 2020.
  • Mitsubishi UFJ Asset Management opened 43 new positions and closed 22 in Q4 2020.
  • Mitsubishi UFJ Asset Management's portfolio value rose 19% quarter-over-quarter to $12.9B.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.